Shanghai, China

Pingzhao Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pingzhao Zhang. Retrieved from https://idiyas.com/inventor/pingzhao-zhang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Pingzhao Zhang

Introduction

Pingzhao Zhang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of polynucleotides and their applications. His work has implications for medical research and therapeutic advancements.

Latest Patents

Pingzhao Zhang holds a patent for a groundbreaking invention titled "Polynucleotide, vector, host cell and method for producing human hepatoma-derived growth factor 5 polypeptide." This invention provides a cDNA sequence of human hepatoma-derived growth factor 5 (HDGF5). The patent also relates to the polypeptides encoded by the nucleotide sequences, their uses, and the methods for producing HDGF5 polynucleotides and polypeptides. He has 1 patent to his name.

Career Highlights

Throughout his career, Pingzhao Zhang has focused on innovative research that bridges molecular biology and therapeutic applications. His work has been instrumental in advancing our understanding of growth factors and their potential uses in medicine.

Collaborations

Pingzhao Zhang has collaborated with notable colleagues, including Zekun Guo and Long Yu. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Pingzhao Zhang's contributions to biotechnology and his innovative patent highlight his role as a significant inventor in the field. His work continues to influence research and development in medical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…